Modulation of multidrug resistance by verapamil or mdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers in mdr-resistant human carcinoma (LoVo) line.
第一作者:
L,Rivoltini
第一单位:
Division of Experimental Oncology D, Istituto Nazionale Tumori, Milan, Italy.
作者:
医学主题词
腺癌(Adenocarcinoma);结肠肿瘤(Colonic Neoplasms);多柔比星(Doxorubicin);抗药性(Drug Resistance);基因表达调控(Gene Expression Regulation);人类(Humans);杀伤细胞, 淋巴因子激活(Killer Cells, Lymphokine-Activated);巨噬细胞(Macrophages);膜糖蛋白类(Membrane Glycoproteins);寡核苷酸类, 反义(Oligonucleotides, Antisense);肿瘤细胞, 培养的(Tumor Cells, Cultured);维拉帕米(Verapamil)
DOI
10.1002/ijc.2910460429
PMID
1976601
发布时间
2019-07-08
- 浏览18
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



